Literature DB >> 15388251

Structural and functional anatomy of the globular domain of complement protein C1q.

Uday Kishore1, Rohit Ghai, Trevor J Greenhough, Annette K Shrive, Domenico M Bonifati, Mihaela G Gadjeva, Patrick Waters, Mihaela S Kojouharova, Trinad Chakraborty, Alok Agrawal.   

Abstract

C1q is the first subcomponent of the classical pathway of the complement system and a major connecting link between innate and acquired immunity. As a versatile charge pattern recognition molecule, C1q is capable of engaging a broad range of ligands via its heterotrimeric globular domain (gC1q) which is composed of the C-terminal regions of its A (ghA), B (ghB) and C (ghC) chains. Recent studies using recombinant forms of ghA, ghB and ghC have suggested that the gC1q domain has a modular organization and each chain can have differential ligand specificity. The crystal structure of the gC1q, molecular modeling and protein engineering studies have combined to illustrate how modular organization, charge distribution and the spatial orientation of the heterotrimeric assembly offer versatility of ligand recognition to C1q. Although the biochemical and structural studies have provided novel insights into the structure-function relationships within the gC1q domain, they have also raised many unexpected issues for debate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388251      PMCID: PMC3818097          DOI: 10.1016/j.imlet.2004.06.015

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  149 in total

Review 1.  Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity.

Authors:  Gérard J Arlaud; Christine Gaboriaud; Nicole M Thielens; Monika Budayova-Spano; Véronique Rossi; Juan Carlos Fontecilla-Camps
Journal:  Mol Immunol       Date:  2002-11       Impact factor: 4.407

2.  Direct binding of C1q to apoptotic cells and cell blebs induces complement activation.

Authors:  Alma J Nauta; Leendert A Trouw; Mohamed R Daha; Odette Tijsma; Rienk Nieuwland; Wilhelm J Schwaeble; Alexandre R Gingras; Alberto Mantovani; Erik C Hack; Anja Roos
Journal:  Eur J Immunol       Date:  2002-06       Impact factor: 5.532

3.  CDART: protein homology by domain architecture.

Authors:  Lewis Y Geer; Michael Domrachev; David J Lipman; Stephen H Bryant
Journal:  Genome Res       Date:  2002-10       Impact factor: 9.043

4.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

5.  Differential activation of human and guinea pig complement by pentameric and hexameric IgM.

Authors:  Cathy Collins; Florence W L Tsui; Marc J Shulman
Journal:  Eur J Immunol       Date:  2002-06       Impact factor: 5.532

6.  A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide.

Authors:  Alok Agrawal; Melanie J Simpson; Steven Black; Marianne P Carey; David Samols
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

Review 7.  gC1q-R/p33: structure-function predictions from the crystal structure.

Authors:  Berhane Ghebrehiwet; Jolyon Jesty; Ellinor I B Peerschke
Journal:  Immunobiology       Date:  2002-09       Impact factor: 3.144

Review 8.  Recent progress in the understanding of the structure-function relationships of the globular head regions of C1q.

Authors:  Uday Kishore; Mihaela S Kojouharova; Kenneth B M Reid
Journal:  Immunobiology       Date:  2002-09       Impact factor: 3.144

Review 9.  Interaction of C1q and mannan-binding lectin with viruses.

Authors:  Nicole M Thielens; Pascale Tacnet-Delorme; Gérard J Arlaud
Journal:  Immunobiology       Date:  2002-09       Impact factor: 3.144

Review 10.  C1q, autoimmunity and apoptosis.

Authors:  Marina Botto; Mark J Walport
Journal:  Immunobiology       Date:  2002-09       Impact factor: 3.144

View more
  56 in total

1.  Gene expression analysis of SCC tumor cells in muscle tissue.

Authors:  Walter Hundt; Esther L Yuh; Mykhaylo Burbelko; Andreas Kiessling; Mark D Bednarski; Silke Steinbach
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-15       Impact factor: 2.503

2.  Human C-reactive protein protects mice from Streptococcus pneumoniae infection without binding to pneumococcal C-polysaccharide.

Authors:  Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson; Alok Agrawal
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

Review 3.  Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Authors:  Hadi Abou-El-Hassan; Hassan Zaraket
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-26

4.  Properdin binding to complement activating surfaces depends on initial C3b deposition.

Authors:  Morten Harboe; Christina Johnson; Stig Nymo; Karin Ekholt; Camilla Schjalm; Julie K Lindstad; Anne Pharo; Bernt Christian Hellerud; Kristina Nilsson Ekdahl; Tom Eirik Mollnes; Per H Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

5.  Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.

Authors:  Lee Aun Tan; Andrew C Yang; Uday Kishore; Robert B Sim
Journal:  Protein Cell       Date:  2011-05-15       Impact factor: 14.870

Review 6.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

Review 7.  Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.

Authors:  Thomas Klonisch; Aleksandra Glogowska; Thatchawan Thanasupawat; Maxwell Burg; Jerry Krcek; Marshall Pitz; Appalaraju Jaggupilli; Prashen Chelikani; G William Wong; Sabine Hombach-Klonisch
Journal:  Br J Pharmacol       Date:  2016-08-11       Impact factor: 8.739

8.  A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma.

Authors:  Emilian Racila; Brian K Link; Wen-Kai Weng; Thomas E Witzig; Stephen Ansell; Matthew J Maurer; Jian Huang; Christopher Dahle; Ahmad Halwani; Ronald Levy; George J Weiner
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

Review 9.  Discrimination between host and pathogens by the complement system.

Authors:  Michael K Pangburn; Viviana P Ferreira; Claudio Cortes
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

10.  Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection.

Authors:  Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson; Alok Agrawal
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.